A detailed history of Brevan Howard Capital Management LP transactions in Incyte Corp stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 36,789 shares of INCY stock, worth $2.56 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
36,789
Previous 22,723 61.9%
Holding current value
$2.56 Million
Previous $1.38 Million 76.54%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$57.33 - $68.61 $806,403 - $965,068
14,066 Added 61.9%
36,789 $2.43 Million
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $465,277 - $579,551
9,091 Added 66.69%
22,723 $1.38 Million
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $410,835 - $483,776
7,265 Added 114.1%
13,632 $776,000
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $332,102 - $408,697
6,367 New
6,367 $399,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.